Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: Systematic review and meta-analysis

Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: Systematic review and meta-analysis

Objective: Animal studies suggested that angiotensin-converting enzyme inhibitors (ACEi) and angiotensin-receptor blockers (ARB) facilitate the inoculation of potentially leading to a higher risk of infection and/or disease severity. We aimed to systematically evaluate the risk of COVID-19 infection...

Full description

Bibliographic Details
Main Authors: Daniel Caldeira, Mariana Alves, Ryan Gouveia e Melo, Pedro Silvério António, Nélson Cunha, Afonso Nunes-Ferreira, Luisa Prada, João Costa, Fausto J Pinto
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
Coronavirus
SARS-CoV-2
Angiotensin-converting enzyme inhibitor
Angiotensin-receptor blocker
Acute respiratory distress syndrome
Acute lung injury
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906720303250

Internet

http://www.sciencedirect.com/science/article/pii/S2352906720303250

Similar Items